Skip to main content
. 2016 Sep 29;115(9):1024–1031. doi: 10.1038/bjc.2016.283

Table 1. Clinicopathological features.

  N %
Age (years)
⩽40 157 12.7
41–50 273 22.1
51–65 531 43
66–75 210 17
>75 64 5.2
Clinical tumour size (cT)
T0 213 17.3
T1 675 54.7
T2 310 25.1
T3 36 2.9
Unknown 3  
Pathological tumour size (mm)
0–5 76 6.2
5.1–10 190 15.4
10.1–20 549 44.6
20.1–30 243 19.8
>30 172 14
Pathological subtype
Ductal 1051 85
Lobular 58 4.7
Mixed 5 0.4
Medullary 42 3.4
Others 81 6.5
Tumour grade
1 95 7.7
2 291 23.5
3 822 66.5
Unknown 29 2.3
LVI
No 848 68.6
Yes 277 22.4
Unknown 112 9
Pathological ALN status
pN0 951 77.2
pN0(i+) 35 2.8
pN1mic 55 4.5
pN1 191 15.5
Metastatic evolution
No 1089 88
Yes 148 12
Breast surgical resection
Conservative 613 81
Mastectomy 144 19
SLN biopsy
No 348 28.1
Yes 889 71.9
ALN dissection
No 648 52.4
Yes 588 47.6
Adjuvant chemotherapy
No 288 23.3
Yes 949 76.7

Abbreviations: ALN=axillary lymph node; LVI=lymphovascular invasion; N=number of patients; pN=pathological lymph onde involvement; SLN=sentinel lymph node.